No Data
No Data
Applied Therapeutics(APLT.US) Officer Sells US$4.71 Million in Common Stock
Optimistic Buy Rating for Applied Therapeutics Amid Positive Drug Approval Prospects
Express News | Applied Therapeutics Expects That Its Cash And Cash Equivalents Of $122.2M Will Fund The Business Into 2026
Express News | Applied Therapeutics Q2 2024 GAAP EPS $(0.13) Beats $(0.15) Estimate, Sales $144.000K May Not Be Comparable To $2.500M Estimate
Applied Therapeutics | 10-Q: Q2 2024 Earnings Report
Earnings Flash (APLT) APPLIED THERAPEUTICS Posts Q2 Revenue $144,000
No Data